|
|
|
|
|
|
|
|
|
|
CONCLUSIONS/SIGNIFICANCE: We provide evidence for a major role for BRCA1 mRNA expression as a marker of time to progression and overall survival in sporadic breast cancers treated with anthracycline-based chemotherapy. These findings can be useful for customizing chemotherapy.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.